PARTIAL DOPAMINE-D2 RECEPTOR AGONIST PLUS SEROTONIN AND/ODER NORADRENALINE INHIBITOR ACTIVITY

摘要

The invention relates to the use of a compound or a combination of compounds having partial dopamine-D2 receptor agonistic activity and serotonin and/or noradrenaline reuptake inhibitory activity, for the preparation of a pharmaceutical composition for the treatment of psychiatric and/or neurologic disorders caused by disturbances of the major monoaminergic dopamine, serotonin and/or nordrenaline systems or that can be treated via manipulation of those systems.